Transtinib is a novel and potent EGFR tyrosine kinase inhibitor (EGFR-TKI) with anticancer activity. It exhibits activity against L858R/T790M mutant NSCLC cell lines and xenografts.

纯度：≥98%

CAS：1246089-27-9